Zobrazeno 1 - 10
of 39
pro vyhledávání: '"C. M. Tanner"'
Autor:
A. W. Willis, E. Roberts, J. C. Beck, B. Fiske, W. Ross, R. Savica, S. K. Van Den Eeden, C. M. Tanner, C. Marras, on behalf of the Parkinson’s Foundation P4 Group
Publikováno v:
npj Parkinson's Disease, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract Parkinson disease (PD) is the second most common age-related neurodegenerative condition diagnosed in North America. We recently demonstrated, using multiple epidemiological data sources, that the prevalence of PD diagnoses was greater than
Externí odkaz:
https://doaj.org/article/0ca667c8ce5e4fc48090bdc2d33f0db1
Publikováno v:
Journal of the American Veterinary Medical Association. 243(5)
Autor:
R A, Popat, S K, Van Den Eeden, C M, Tanner, F, Kamel, D M, Umbach, K, Marder, R, Mayeux, B, Ritz, G W, Ross, H, Petrovitch, B, Topol, V, McGuire, S, Costello, A D, Manthripragada, A, Southwick, R M, Myers, L M, Nelson
Publikováno v:
European journal of neurology. 18(5)
In 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine animal models of Parkinson's disease (PD), caffeine protects neurons by blocking the adenosine receptor A2A (ADORA2A). Caffeine is primarily metabolized by cytochrome P450 1A2 (CYP1A2). Our objective wa
Autor:
C M, Tanner
Publikováno v:
Neurologic Clinics
Additional epidemiologic studies may provide important insights into the etiology of Parkinson's disease. Moreover as the elderly population of Europe and the United States grows, accurate public health planning requires accurate incidence and preval
Publikováno v:
Journal of neural transmission. Supplementum. (70)
Study of the nongenetic causes of Parkinson's disease (PD) was encouraged by discovery of a cluster of parkinsonism produced by neurotoxic pyridine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the 1980s. Since that time, epidemiologic inves
Autor:
D M, Togasaki, C M, Tanner
Publikováno v:
Advances in neurology. 82
Autor:
C M, Tanner, Y, Ben-Shlomo
Publikováno v:
Advances in neurology. 80
Publikováno v:
JAMA. 281(4)
The cause of Parkinson disease (PD) is unknown. Genetic linkages have been identified in families with PD, but whether most PD is inherited has not been determined.To assess genetic inheritance of PD by studying monozygotic (MZ) and dizygotic (DZ) tw
Autor:
V. P. Calabrese, E .R. Dorsey, R . Constantinescu, J .P. Thompson, K .M. Biglan, R .G. Holloway, K . Kieburtz, F .J. Marshall, B .M. Ravina, G . Schifitto, A . Siderowf, C .M. Tanner
Publikováno v:
Neurology. 69:223-224
Autor:
Jeffrey R. Idle, Martha S. Sandy, Donato A. Di Monte, J. W. Langston, Martin Armstrong, Ann K. Daly, C. M. Tanner
Publikováno v:
Neurology. 47(1)
Parkinson's disease (PD) is thought to develop as a result of interactions between genetic susceptibility factors and environmental exposures.One candidate gene is CYP2D6, which codes for the debrisoquine 4-hydroxylase cytochrome P450. Impairment of